Ishika Desai is an associate in Goodwin’s Intellectual Property Litigation practice. She concentrates her practice on complex commercial disputes, with a focus on technology clients and trade secret litigation, including trade secret litigation relating to employee mobility and trade secret litigation between competitors. She joined Goodwin in 2021.
Representative Matters
- Represented Rivian in defense of trade secret misappropriation case filed against Rivian by Tesla
- Representing cyber risk management firm in trade secret litigation
- Represented social media company in trade secret and copyright litigations
- Represented life sciences and diagnostics company in environmental litigation
- Represented prominent legal scholars in connection with amicus brief filed in the Supreme Court of the United States and various U.S. Courts of Appeals
Professional Experience
While attending law school, Ishika served as a judicial extern to the Honorable Chief Justice Tani Cantil-Sakauye of the California Supreme Court. She was also the Diversity, Equity, and Inclusion Editor of the UC Davis Law Review, a member of the King Hall Negotiations Team’s Executive Board, and worked as a research and teaching assistant.
Credentials
Education
JD2021
University of California, Davis School of Law
BS2018
The Ohio State University
Admissions
Bars
- California
Recognition & Awards
During law school, Ishika received the Outstanding Oral Advocate Award, as well as the Best Cross Examination Award in the 2018 Cota Mock Trial Competition. She also received Witkin awards in Contracts and Torts.
Thought Leadership
- Co-Author, “Navigating the NDCA'S New Whistleblower Protections in the Context of Trade Secret Misappropriation Claims,” California Lawyer Daily Journal, September 6, 2024
- Co-Author, “California Supreme Court Review: July 2023,” Los Angeles and San Francisco Daily Journal, August 3, 2023
- Co-Author, “California Supreme Court Review: December 2022,” Los Angeles and San Francisco Daily Journal, December 30, 2022
- Co-Author, “Treble damages among a handful of recent important decisions,” Los Angeles & San Francisco Daily Journal, September 8, 2022
- Co-Author, “Grouping of Carbonaceous Nanomaterials Based on Association of Patterns of Inflammatory Markers in BAL Fluid with Adverse Outcomes in Lungs,” Nanotoxicology, July 30, 2019